Publikationen, an denen er mitarbeitet Vicente Bertomeu González (27)

2024

  1. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

  2. Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary syndromes

    Medicina Clinica

2022

  1. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

    European Journal of Internal Medicine, Vol. 99, pp. 45-56

  2. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC Medicine, Vol. 20, Núm. 1

  3. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 5, pp. 721-728

  4. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

  5. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

  6. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

2021

  1. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  2. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    BMC Medicine, Vol. 19, Núm. 1

  3. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  4. The determinant effect of competing events in the analysis of heart failure incidence after myocardial infarction

    European Journal of Preventive Cardiology

2020

  1. Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition

    Thrombosis Research

2019

  1. Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome

    International Journal of Cardiology, Vol. 276, pp. 20-25

2018

  1. Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication

    International Journal of Cardiology, Vol. 270, pp. 36-41

2013

  1. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 103-109

2011

  1. Anticoagulation prescription in atrial fibrillation

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 10, pp. 1473-1479

  2. Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension

    Journal of Human Hypertension, Vol. 25, Núm. 10, pp. 600-607

  3. Differential effect of β-blockers for heart rate control in coronary artery disease

    Clinical Cardiology, Vol. 34, Núm. 12, pp. 748-754

  4. Factores asociados a la falta de control de la hipertensión arterial en pacientes con y sin enfermedad cardiovascular

    Revista Espanola de Cardiologia, Vol. 64, Núm. 7, pp. 587-593